Ajooni Biotech growth over the years

·UnclassifiedChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+59.1%+34.8%
EBITDA+69.7%+31.3%
Net Income+28.2%+56.6%
EPS (adj.)+28.2%+56.6%
Total Assets+26.7%+27.0%
Total Equity+3.5%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

AJOONI₹2.90

Ajooni Biotech Limited

· Unclassified
₹ CrorePeersTOUCHWOODRKECRAJMETBANKAAAKASHGANGAFORGEGLOBEAGROPHOSMcap ₹50 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+59.1+34.8
EBITDA+69.7+31.3
Net Income+28.2+56.6
EPS (adj.)+28.2+56.6
Total Assets+26.7+27.0
Total Equity+3.5—
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.